Unknown

Dataset Information

Analyses of reported severe adverse events after immunization with SARS-CoV-2 vaccines in the United States: One year on.


ABSTRACT:

Objective

To analyze rates of reported severe adverse events after immunization (sAEFI) attributed to SARS-CoV-2 vaccines in the United States (US) using safety surveillance data.

Methods

Observational study of sAEFI reported to the vaccine adverse events reporting system (VAERS) between December 13, 2020, to December 13, 2021, and attributed to SARS-CoV-2 vaccination programs across all US states and territories. All sAEFI in conjunction with mRNA (BNT-162b2 or mRNA-1273) or adenovector (Ad26.COV2.S) vaccines were included. The 28-day crude cumulative rates for reported emergency department (ED) visits and sAEFI viz. hospitalizations, life-threatening events and deaths following SARS-CoV-2 vaccination were calculated. Incidence rate ratios (IRRs) of reported sAEFI were comp

SUBMITTER: Mangat HS 

PROVIDER: S-EPMC9610110 | biostudies-literature | 2022

REPOSITORIES: biostudies-literature